[Treatment of migraine during pregnancy and breast feeding].
Hagen
Knut
K
Nasjonalt kompetansesenter for hodepine, Institutt for nevromedisin, Det medisinske fakultet, Norges teknisk-naturvitenskapelige universitet og Avdeling for nevrologi og klinisk nevrofysiologi, St. Olavs Hospital 7006, Trondheim. knut.hagen@ntnu.no
Stovner
Lars Jacob
LJ
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000700:Analgesics / Q000009:adverse effects*; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects; D001942:Breast Feeding; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000517:prevention & control; D012307:Risk Factors; D017366:Serotonin Receptor Agonists / Q000009:adverse effects*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents